Centrapraz Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Adverse Reactions

Safety Experience with Intravenous Pantoprazole: Intravenous Pantoprazole has been studied in clinical trials in several populations including patients with GERD and a history of erosive esophagitis, patients with Zollinger-Ellison syndrome, patients involved in clinical trials for other disorders which may respond to proton pump inhibitor therapy, and healthy subjects. Adverse experiences occurring in >1% of patients treated with intravenous Pantoprazole (n=836) in domestic or international clinical trials are shown as follows by body system. In most instances, the relationship to Pantoprazole was unclear.
Respiratory system: Rhinitis.
Head-to-head comparative studies between Pantoprazole and other oral proton pump inhibitors (oral or I.V.), or H2 receptor antagonists (oral or I.V.) have been limited. The available information does not provide sufficient evidence to distinguish the safety profile of these regimens.

View ADR Reporting Link

pantoprazole

Manufacturer:

Stallion Labs

Distributor:

Central West Medicale

Marketer:

Ambica